What is DF/HCC?
• DF/HCC is a comprehensive cancer center designated by the National Cancer Institute and is the first collaborative effort to bring together the intellectual resources of the seven institutions to focus on one missionthe eradication of cancer. • The CURE program is housed within DF/HCCs Initiative to Eliminate Cancer Disparities. The Initiative uses an integrative approach to focus on disparities reduction throughout all aspects of DF/HCC structure and activities through facilitation of clinical trials recruitment efforts, original research focused on new discoveries related to understanding the causes of and solutions to cancer disparities, as well as development of increased faculty and trainee diversity. The CURE program is designed to introduce student participants to the exciting world of cancer research at our seven partner institutions – Beth Isreal Deaconess Medical Center, Brigham and Women’s Hospital, Children’s Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical
